PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Transparency Market Research

Press Release


Receive press releases from Transparency Market Research: By Email RSS Feeds:

Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2% Research Report Submitted by Transparency Market Research


Transparency Market Research Report Adds "Insulin Market - Global And China Industry Analysis, Size, Share, Growth, And Forecast 2011 - 2018 " to its database.

Albany, NY, June 26, 2013 --(PR.com)-- According to a new market report published by Transparency Market Research "Insulin Market - Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018" the global insulin market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018, growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected to increase its share in the global insulin market to 10.2% by 2018.

Browse the full report at http://www.transparencymarketresearch.com/insulin-market.html

The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin and not even being diagnosed. This however, presents a huge supply demand deficit for insulin, with high growth potential in developing markets. The factors contributing to the insulin market growth also includes increase in global expenditure on healthcare, strong distribution network, and high scope in developing economies such as China and India.

It is estimated that worldwide, by year 2030, one in ten people will suffer from diabetes, giving rise to huge demand for insulin. China, being the most populous nation in the world, accounts for the largest share of the global diabetic population and eventually turns out as the most lucrative market for insulin manufacturers.

The China insulin market is projected to grow at a CAGR twice that of the global insulin market. It was estimated at USD 723.8 million in 2011, and is projected to reach USD 3,299.1 million in the year 2018, growing at a CAGR of 24.6%. Currently, China accounts for 6.1% of the global insulin market in terms of volume, which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected to grow at a CAGR of 7.9% from 2012 - 2018.

The global insulin market has continuously witnessed new advanced product types being introduced in the market by insulin manufacturers. The recent product type is modern insulin, which is a genetically engineered version of human insulin, and has been selectively modified to counter the issues associated with human insulin. Currently, modern insulin accounts for more than 76% of the global insulin market.

To meet the rising demand, global insulin manufacturers are not only augmenting existing production facilities, but also expanding their global presence to meet the supply demand gap. Leading insulin manufacturers are now focusing on reinforcing their market leadership in China. It includes key global and China insulin market players such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for more than 90% of the global insulin market share.

This research is specially designed to estimate and analyze the demand and performance of the global and China insulin market in the current market scenario. This research provides in-depth analysis of insulin manufacturers, product sales, trend analysis by segments, and demand by geography. The report covers all the major product segments of the global and China insulin market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered.

The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global and China insulin market as below:
By Action
• Short Acting
• Pre-mixes
• Long Acting
By Type
• Modern
• Human
• Animal

By Purchase Type
• Dosage
• Bulk

Browse Blogs :
http://medicalcaremarketnews.wordpress.com/

http://globalmarketresearchreports.wordpress.com/
Contact Information
Transparency Market Research
Sheela Ak
+1-518-618-1030
Contact
http://www.transparencymarketresearch.com
90 State Street,
Suite 700,
Albany, NY - 12207
United States

Click here to view the list of recent Press Releases from Transparency Market Research
Promote Your Business